8259

0

MADHAVBAUG

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VAIDYA SANE AYUR LAB LTD Share Price Today

VAIDYA SANE AYUR LAB LTD is currently trading at ₹183.9, up by ₹3.19 from the previous close. The stock touched an intraday high of ₹183.90 and a low of ₹181.00 during the latest trading session. Over the past one year, VAIDYA SANE AYUR LAB LTD has delivered a return of 15.8%, while the stock has declined 26.16% in the last one month.

VAIDYA SANE AYUR LAB LTD performance

Today’s low Today’s high
₹ 181.00 ₹ 183.90
₹ 182.55
52 week low 52 week high
₹ 143.50 ₹ 335.00
₹ 182.55
Open Price ₹ 182.00
Prev. Close ₹ 180.70
Volume (Shares) 11200.00
Total traded value ₹ 20.44
Upper Circuit ₹ 216.80
Lower Circuit ₹ 144.60
info

Investment Returns

Over 1 Month -26.16% Over 3 Months -11.34% Over 6 Months -30.37% Over 1 Year 15.80%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VAIDYA SANE AYUR LAB LTD fundamentals


  • Market cap (Cr) 191.90
  • P/E Ratio (TTM) 38.53
  • Beta 0.80
  • Book Value / share 76.46
  • Return on equity 10.04%
  • EPS (TTM) 4.69
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.00
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

VAIDYA SANE AYUR LAB LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 99.62
Operating Expense 95.73
Net Profit 4.93
Net Profit Margin (%) 4.94
Earnings Per Share (EPS) 4.69
EBITDA 12.51
Effective Tax Rate (%) 18.88
Particulars MAR 2025 (Values in Cr)
Revenue 87.11
Operating Expense 80.79
Net Profit 4.90
Net Profit Margin (%) 5.62
Earnings Per Share (EPS) 4.66
EBITDA 11.46
Effective Tax Rate (%) 28.67
Particulars MAR 2024 (Values in Cr)
Revenue 97.33
Operating Expense 97.44
Net Profit 1.05
Net Profit Margin (%) 1.07
Earnings Per Share (EPS) 0.99
EBITDA 4.72
Effective Tax Rate (%) 28.27
Particulars MAR 2023 (Values in Cr)
Revenue 99.03
Operating Expense 93.48
Net Profit 5.19
Net Profit Margin (%) 5.24
Earnings Per Share (EPS) 4.94
EBITDA 9.70
Effective Tax Rate (%) 24.89
Particulars MAR 2022 (Values in Cr)
Revenue 74.71
Operating Expense 70.30
Net Profit 3.47
Net Profit Margin (%) 4.64
Earnings Per Share (EPS) 8.00
EBITDA 7.24
Effective Tax Rate (%) 26.94
Particulars MAR 2025 (Values in Cr)
Book Value / Share 59.44
ROE % 13.58
ROCE % 17.67
Total Debt to Total Equity 0.03
EBITDA Margin 17.09
Particulars MAR 2024 (Values in Cr)
Book Value / Share 40.10
ROE % 3.19
ROCE % 5.42
Total Debt to Total Equity 0.02
EBITDA Margin 5.95
Particulars MAR 2023 (Values in Cr)
Book Value / Share 38.48
ROE % 11.94
ROCE % 17.30
Total Debt to Total Equity 0.00
EBITDA Margin 9.97
Particulars MAR 2025 (Values in Cr)
Book Value / Share 56.78
ROE % 10.04
ROCE % 13.28
Total Debt to Total Equity 0.03
EBITDA Margin 13.66
Particulars MAR 2024 (Values in Cr)
Book Value / Share 39.56
ROE % 1.65
ROCE % 2.97
Total Debt to Total Equity 0.02
EBITDA Margin 4.65
Particulars MAR 2023 (Values in Cr)
Book Value / Share 38.82
ROE % 13.54
ROCE % 19.16
Total Debt to Total Equity 0.02
EBITDA Margin 10.46
Particulars MAR 2022 (Values in Cr)
Book Value / Share 34.13
ROE % 15.20
ROCE % 20.93
Total Debt to Total Equity 0.05
EBITDA Margin 10.25
Particulars MAR 2021 (Values in Cr)
Book Value / Share 2170.44
ROE % 10.34
ROCE % 14.76
Total Debt to Total Equity 0.39
EBITDA Margin 8.74
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.36
Total Assets 76.70
Total Liabilities 76.70
Total Equity 62.53
Share Outstanding 1
Price to Book Ratio 1.65
Return on Assets (%) 9.32
Return on Capital (%) 11.18
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.37
Total Assets 69.71
Total Liabilities 69.71
Total Equity 55.60
Share Outstanding 1
Price to Book Ratio 4.40
Return on Assets (%) 2.84
Return on Capital (%) 3.46
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.76
Total Assets 54.88
Total Liabilities 54.88
Total Equity 40.45
Share Outstanding 1
Price to Book Ratio 6.05
Return on Assets (%) 8.80
Return on Capital (%) 11.91
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.32
Total Assets 73.82
Total Liabilities 73.82
Total Equity 59.70
Share Outstanding 1
Price to Book Ratio 1.65
Return on Assets (%) 6.63
Return on Capital (%) 8.01
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.18
Total Assets 70.73
Total Liabilities 70.73
Total Equity 55.02
Share Outstanding 1
Price to Book Ratio 4.40
Return on Assets (%) 1.47
Return on Capital (%) 1.84
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.75
Total Assets 55.27
Total Liabilities 55.27
Total Equity 40.80
Share Outstanding 1
Price to Book Ratio 6.05
Return on Assets (%) 9.38
Return on Capital (%) 12.68
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.56
Total Assets 50.00
Total Liabilities 50.00
Total Equity 35.88
Share Outstanding 1
Price to Book Ratio 5.71
Return on Assets (%) 6.93
Return on Capital (%) 9.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.90
Total Assets 25.80
Total Liabilities 25.80
Total Equity 9.76
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 1.51
Return on Capital (%) 3.64
Particulars MAR 2025 (Values in Cr)
Net Income 9.89
Cash from Operations 12.47
Cash from Investing -10.07
Cash from Financing -0.53
Net change in Cash -0.01
Free Cash Flow 20.92
Particulars MAR 2024 (Values in Cr)
Net Income 2.86
Cash from Operations -0.38
Cash from Investing -12.99
Cash from Financing 14.86
Net change in Cash 0.60
Free Cash Flow 10.76
Particulars MAR 2023 (Values in Cr)
Net Income 6.43
Cash from Operations 2.68
Cash from Investing 0.51
Cash from Financing -1.37
Net change in Cash -0.79
Free Cash Flow 9.66
Particulars MAR 2025 (Values in Cr)
Net Income 6.86
Cash from Operations 8.60
Cash from Investing -6.90
Cash from Financing -0.54
Net change in Cash 0.13
Free Cash Flow 15.87
Particulars MAR 2024 (Values in Cr)
Net Income 1.45
Cash from Operations 4.20
Cash from Investing -17.42
Cash from Financing 14.46
Net change in Cash 0.43
Free Cash Flow 9.29
Particulars MAR 2023 (Values in Cr)
Net Income 6.91
Cash from Operations 2.19
Cash from Investing 0.99
Cash from Financing -1.37
Net change in Cash -0.80
Free Cash Flow 9.17
Particulars MAR 2022 (Values in Cr)
Net Income 4.74
Cash from Operations -12.12
Cash from Investing -7.52
Cash from Financing 22.49
Net change in Cash 1.65
Free Cash Flow -8.95
Particulars MAR 2021 (Values in Cr)
Net Income 1.60
Cash from Operations 6.38
Cash from Investing -0.66
Cash from Financing -5.25
Net change in Cash -0.15
Free Cash Flow 7.29
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8354.55 61.41 12.68 120125.61 6680.00 8490.30
FORTIS MALAR HOSPITALS LIMITED 53.95 24.41 2.94 101.11 40.75 77.00
SHREE PACETRONIX LTD. 142.05 16.95 2.99 53.26 66.10 283.15
TRANSGENE BIOTEK LTD. 3.04 0.00 2.74 23.03 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTERPRISE LT 8354.55 80.02 12.05 120125.61 6680.00 8490.30
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.36 0.00 -9.57 29.40 30.30 57.48
KOVAI MEDICAL CENTER & HO 5515.95 24.68 4.57 6034.45 5010.00 6725.00

VAIDYA SANE AYUR LAB LTD shareholding pattern

Holding
33.66%
66.33%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

VAIDYA SANE AYUR LAB LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
182.55 1.02 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 185.00
  • 26 Days 201.90
  • 10 Days 188.90
  • 50 Days 210.10
  • 12 Days 191.00
  • 100 Days 220.10
  • 20 Days 198.30
  • 200 Days 220.60
186.47 PIVOT
First Support 184.53 First Resistance 188.73 Second Support 182.27 Second Resistance 190.67 Third Support 180.33 Third Resistance 192.93
RSI 40.70 ADX 23.12 MACD -10.78 Williams % R -66.00 Commodity Channel Index (CCI) -53.62
Date 2026-06-08 Week 4733.00 Same Day 3200.00 Month 11848.00
1 Year 0.83 3 Year 0.57
Over 1 Month
-26.16% down
Over 1 Year
15.80% down
Over 3 Months
-11.34% down
Over 3 Years
-9.13% down
Over 6 Months
-30.37% down
Over 5 Years
12.12% down

VAIDYA SANE AYUR LAB LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
05 Sep 2023 0.25 Final 06 Sep 2023 Equity shares
18 Nov 2022 0.25 Interim 18 Nov 2022 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Vaidya Sane Ayurved Laboratories Ltd?

Answer Field

Vaidya Sane Ayurved Laboratories Ltd share price is for NSE ₹ 183.90 & for BSE ₹ 0.00 as on Jun 10 2026 03:22 PM.

What is the Market Cap of Vaidya Sane Ayurved Laboratories Ltd Share?

Answer Field

The market cap of Vaidya Sane Ayurved Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 10 2026 03:22 PM.

What is the 52 Week High and Low of Vaidya Sane Ayurved Laboratories Ltd?

Answer Field

The 52 Week High and Low of Vaidya Sane Ayurved Laboratories Ltd for NSE is ₹ 335.00 and ₹ 143.50 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Vaidya Sane Ayurved Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been 12.02%.

What is the P/E Ratio of Vaidya Sane Ayurved Laboratories Ltd Share?

Answer Field

As on Jun 10 2026 03:22 PM the price-to-earnings (PE) ratio for Vaidya Sane Ayurved Laboratories Ltd share is 38.53.

What is the PB ratio of Vaidya Sane Ayurved Laboratories Ltd Share?

Answer Field

As on Jun 10 2026 03:22 PM, the price-to-book (PB) ratio for Vaidya Sane Ayurved Laboratories Ltd share is 76.46.

How to Buy Vaidya Sane Ayurved Laboratories Ltd Share?

Answer Field

You can trade in Vaidya Sane Ayurved Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vaidya Sane Ayurved Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Vaidya Sane Ayurved Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vaidya Sane Ayurved Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|